Federal University of Rio Grande do Sul
ufrgs.brTotal trials
118
Active
13
Phase 3
1
Total enrollment
23,589
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Bipolar Disorder5
- Parkinson Disease5
- Aging5
- Obesity4
- Gingival Recession4
- Periodontitis3
- Diabetes Mellitus, Type 23
- Attention Deficit Hyperactivity Disorder3
Frequently asked questions about Federal University of Rio Grande do Sul
- How many clinical trials does Federal University of Rio Grande do Sul have on ClinicalTrials.gov?
- Federal University of Rio Grande do Sul is listed as the lead sponsor on 118 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Federal University of Rio Grande do Sul's trials are in Phase 3?
- 1 of Federal University of Rio Grande do Sul's trials are in Phase 3.
- What therapeutic areas does Federal University of Rio Grande do Sul focus on?
- Federal University of Rio Grande do Sul's most-studied conditions on ClinicalTrials.gov are Bipolar Disorder, Parkinson Disease, Aging, Obesity, Gingival Recession.